Generic Name and Formulations:
Erenumab-aooe 70mg/mL; soln for SC inj; preservative-free.
RECENT UPDATESMonograph added.
Indications for AIMOVIG:
Prophylaxis of migraine.
Give by SC inj into abdomen, thigh, or upper arm. 70mg once monthly; some patients may benefit from 140mg (given as 2 consecutive 70mg inj) once monthly.
Do not inj into tender, bruised, red, or hard areas. Latex allergy. Elderly. Pregnancy. Nursing mothers.
Calcitonin gene-related peptide (CGRP) receptor antagonist.
Inj site reactions, constipation, cramps, muscle spasms.
Single-dose prefilled SureClick autoinjectors—1, 2; Single-dose prefilled syringes—1, 2
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Belief That Abortion Harms Women's Mental Health Appears Misinformed
- Models Derived From Electronic Health Records Effective in Predicting Suicide Risk
- Probiotics Effective in Reducing Rehospitalization for Patients With Mania
- Caffeine Sodium Benzoate Effective as Electroconvulsive Therapy Augmentation
- Personality Disorders Related to Adverse Outcomes in Bipolar Disorder
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Substance Abuse and Primary Psychosis: A Closer Look
- Schizophrenia, Major Depressive Disorder, Bipolar Disorder Linked With Abnormal Functional Connectivity
- ICF Core Sets for Schizophrenia Validated by International Cohort of Psychiatrists
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Comorbid OCD Confers Greater Neurocognitive Impairment in Schizophrenia
- Smartphone Technology Allows Diagnosis of Autism in ResearchKit Feasibility Study